Canada’s review of Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of 5 to 11 should be completed within the next “one to two weeks,” Health Canada’s chief medical adviser said today.
Decision on Pfizer’s COVID-19 vaccine for younger kids coming within two weeks: Health Canada
